Humasis Conducts 300% Bonus Issue to Enhance Shareholder Value... 'Treasury Stock Cancellation Effect'

Humasis, which achieved record-high performance last year, will conduct a bonus issue to enhance shareholder value.

The in vitro diagnostic device specialist Humasis announced on the 10th through a public disclosure that it has decided on a 300% bonus issue. Three new shares will be allocated for every one existing common share.

The total number of newly issued shares is 95,464,674, and the record date for new share allocation is the 27th of this month. The allocation targets are shareholders registered in the shareholder registry with voting rights as of the record date.

According to the company, this bonus issue was decided not only to activate trading by increasing the number of circulating shares but also to enhance shareholder value. Having recorded the highest performance last year, the company plans to return value to shareholders. Humasis posted sales of 471.3 billion KRW and an operating profit of 214.7 billion KRW last year.

Since treasury shares held by Humasis are excluded from the bonus issue allocation, existing shareholders are expected to benefit from the treasury stock cancellation effect, which increases the value of their shares.

Namgung Gyeon, Chairman of Humasis, stated, "We will continuously seek ways to maximize both corporate value and shareholder value, including expanding existing businesses and strengthening entry into new businesses to secure growth engines."